Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
50.75
+4.17 (8.95%)
At close: Feb 6, 2026, 4:00 PM EST
51.74
+0.99 (1.95%)
After-hours: Feb 6, 2026, 4:03 PM EST
Dianthus Therapeutics Employees
Dianthus Therapeutics had 78 employees as of December 31, 2024. The number of employees increased by 25 or 47.17% compared to the previous year.
Employees
78
Change (1Y)
25
Growth (1Y)
47.17%
Revenue / Employee
$39,462
Profits / Employee
-$1,619,808
Market Cap
2.19B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 78 | 25 | 47.17% |
| Dec 31, 2023 | 53 | 21 | 65.63% |
| Jun 30, 2023 | 43 | - | - |
| Mar 31, 2023 | 32 | - | - |
| Dec 31, 2022 | 32 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,869 |
| Recursion Pharmaceuticals | 800 |
| Galapagos NV | 558 |
| Nuvation Bio | 291 |
| Ocular Therapeutix | 274 |
| Harmony Biosciences Holdings | 268 |
| Soleno Therapeutics | 152 |
| Aurinia Pharmaceuticals | 130 |
DNTH News
- 1 day ago - Dianthus Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 22 days ago - Dianthus Therapeutics, Inc. (DNTH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Leads Biolabs And Dianthus Therapeutics Announce Initiation of Phase 1 Trial Of LBL-047 (DNTH212) In Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) - GlobeNewsWire
- 2 months ago - Dianthus Therapeutics To Participate in the 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 3 months ago - Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results - GlobeNewsWire
- 3 months ago - Dianthus Therapeutics to Participate in Four Investor Conferences During November - GlobeNewsWire
- 3 months ago - Dianthus Therapeutics Highlights New Claseprubart Data Presented During 2025 AANEM Annual Meeting - GlobeNewsWire